Cargando…
Regulation of dopamine transporter activity by carboxypeptidase E
BACKGROUND: The dopamine transporter (DAT) plays a critical role in terminating the action of dopamine by rapid reuptake into the presynaptic neuron. Previous studies have revealed that the DAT carboxyl terminus (DAT-CT) can directly interact with other cellular proteins and regulate DAT function an...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687442/ https://www.ncbi.nlm.nih.gov/pubmed/19419578 http://dx.doi.org/10.1186/1756-6606-2-10 |
_version_ | 1782167532597149696 |
---|---|
author | Zhang, Heping Li, Shupeng Wang, Min Vukusic, Brian Pristupa, Zdenek B Liu, Fang |
author_facet | Zhang, Heping Li, Shupeng Wang, Min Vukusic, Brian Pristupa, Zdenek B Liu, Fang |
author_sort | Zhang, Heping |
collection | PubMed |
description | BACKGROUND: The dopamine transporter (DAT) plays a critical role in terminating the action of dopamine by rapid reuptake into the presynaptic neuron. Previous studies have revealed that the DAT carboxyl terminus (DAT-CT) can directly interact with other cellular proteins and regulate DAT function and trafficking. RESULTS: Here, we have identified that carboxypeptidase E (CPE), a prohormone processing exopeptidase and sorting receptor for the regulated secretory pathway, interacts with the DAT-CT and affects DAT function. Mammalian cell lines coexpressing CPE and DAT exhibited increased DAT-mediated dopamine uptake activity compared to cells expressing DAT alone. Moreover, coexpression of an interfering DAT-CT minigene inhibited the effects of CPE on DAT. Functional changes caused by CPE could be attributed to enhanced DAT expression and subsequent increase in DAT cell surface localization, due to decreased DAT degradation. In addition, CPE association could reduce the phosphorylation state of DAT on serine residues, potentially leading to reduced internalization, thus stabilizing plasmalemmal DAT localization. CONCLUSION: Taken together, our results reveal a novel role for CPE in the regulation of DAT trafficking and DAT-mediated DA uptake, which may provide a novel target in the treatment of dopamine-governed diseases such as drug addiction and obesity. |
format | Text |
id | pubmed-2687442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26874422009-05-28 Regulation of dopamine transporter activity by carboxypeptidase E Zhang, Heping Li, Shupeng Wang, Min Vukusic, Brian Pristupa, Zdenek B Liu, Fang Mol Brain Research BACKGROUND: The dopamine transporter (DAT) plays a critical role in terminating the action of dopamine by rapid reuptake into the presynaptic neuron. Previous studies have revealed that the DAT carboxyl terminus (DAT-CT) can directly interact with other cellular proteins and regulate DAT function and trafficking. RESULTS: Here, we have identified that carboxypeptidase E (CPE), a prohormone processing exopeptidase and sorting receptor for the regulated secretory pathway, interacts with the DAT-CT and affects DAT function. Mammalian cell lines coexpressing CPE and DAT exhibited increased DAT-mediated dopamine uptake activity compared to cells expressing DAT alone. Moreover, coexpression of an interfering DAT-CT minigene inhibited the effects of CPE on DAT. Functional changes caused by CPE could be attributed to enhanced DAT expression and subsequent increase in DAT cell surface localization, due to decreased DAT degradation. In addition, CPE association could reduce the phosphorylation state of DAT on serine residues, potentially leading to reduced internalization, thus stabilizing plasmalemmal DAT localization. CONCLUSION: Taken together, our results reveal a novel role for CPE in the regulation of DAT trafficking and DAT-mediated DA uptake, which may provide a novel target in the treatment of dopamine-governed diseases such as drug addiction and obesity. BioMed Central 2009-05-06 /pmc/articles/PMC2687442/ /pubmed/19419578 http://dx.doi.org/10.1186/1756-6606-2-10 Text en Copyright © 2009 Zhang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Zhang, Heping Li, Shupeng Wang, Min Vukusic, Brian Pristupa, Zdenek B Liu, Fang Regulation of dopamine transporter activity by carboxypeptidase E |
title | Regulation of dopamine transporter activity by carboxypeptidase E |
title_full | Regulation of dopamine transporter activity by carboxypeptidase E |
title_fullStr | Regulation of dopamine transporter activity by carboxypeptidase E |
title_full_unstemmed | Regulation of dopamine transporter activity by carboxypeptidase E |
title_short | Regulation of dopamine transporter activity by carboxypeptidase E |
title_sort | regulation of dopamine transporter activity by carboxypeptidase e |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687442/ https://www.ncbi.nlm.nih.gov/pubmed/19419578 http://dx.doi.org/10.1186/1756-6606-2-10 |
work_keys_str_mv | AT zhangheping regulationofdopaminetransporteractivitybycarboxypeptidasee AT lishupeng regulationofdopaminetransporteractivitybycarboxypeptidasee AT wangmin regulationofdopaminetransporteractivitybycarboxypeptidasee AT vukusicbrian regulationofdopaminetransporteractivitybycarboxypeptidasee AT pristupazdenekb regulationofdopaminetransporteractivitybycarboxypeptidasee AT liufang regulationofdopaminetransporteractivitybycarboxypeptidasee |